Sarcoma  >>  enoblituzumab (MGA271)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
enoblituzumab (MGA271) / MacroGenics
NCT02982941: Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid Tumors

Completed
1
25
US
Enoblituzumab, MGA271
MacroGenics
Neuroblastoma, Rhabdomyosarcoma, Osteosarcoma, Ewing Sarcoma, Wilms Tumor, Desmoplastic Small Round Cell Tumor
05/19
05/19

Download Options